Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Long noncoding RNA DNAJC3-AS1 promotes osteosarcoma progression via its sense-cognate gene DNAJC3.

Liang R, Liu Z, Chen Z, Yang Y, Li Y, Cui Z, Chen A, Long Z, Chen J, Lu J, Huang B, Li Q.

Cancer Med. 2019 Feb;8(2):761-772. doi: 10.1002/cam4.1955. Epub 2019 Jan 16.

2.

Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation.

Chen J, Peng K, Hu D, Shen J, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhang Y, Chen M.

Cancers (Basel). 2018 Oct 10;10(10). pii: E378. doi: 10.3390/cancers10100378.

3.

A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma.

Chen J, Fang A, Chen M, Tuoheti Y, Zhou Z, Xu L, Chen J, Pan Y, Wang J, Zhu H, Zhang Y.

Cancer Med. 2018 Oct;7(10):5027-5035. doi: 10.1002/cam4.1787. Epub 2018 Sep 27.

4.

Upregulation of long non-coding RNA RAB1A-2 induces FGF1 expression worsening lung cancer prognosis.

Wu D, Yang B, Chen J, Xiong H, Li Y, Pan Z, Cao Y, Chen J, Li T, Zhou S, Ling X, Wei Y, Li G, Zhou Y, Qiu F, Yang L, Lu J.

Cancer Lett. 2018 Dec 1;438:116-125. doi: 10.1016/j.canlet.2018.09.016. Epub 2018 Sep 12.

PMID:
30217564
5.

Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis.

Chen J, Lu S, Zhang Y, Xu L, Chen J, Wang J, Chen M, Zhang R, Zhou Z.

J Cancer. 2018 Apr 19;9(10):1745-1753. doi: 10.7150/jca.24568. eCollection 2018.

6.

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study.

Zhang Y, Huang J, Chen J, Yang K, Chen J, Xu L, Zhou Z, Chen M.

Cancer Manag Res. 2018 Mar 27;10:599-611. doi: 10.2147/CMAR.S160047. eCollection 2018.

7.

A functional CNVR_3425.1 damping lincRNA FENDRR increases lifetime risk of lung cancer and COPD in Chinese.

Yang L, Wu D, Chen J, Chen J, Qiu F, Li Y, Liu L, Cao Y, Yang B, Zhou Y, Lu J.

Carcinogenesis. 2018 Mar 8;39(3):347-359. doi: 10.1093/carcin/bgx149.

PMID:
29293945
8.

Long non-coding RNA AGER-1 functionally upregulates the innate immunity gene AGER and approximates its anti-tumor effect in lung cancer.

Pan Z, Liu L, Nie W, Miggin S, Qiu F, Cao Y, Chen J, Yang B, Zhou Y, Lu J, Yang L.

Mol Carcinog. 2018 Mar;57(3):305-318. doi: 10.1002/mc.22756. Epub 2017 Nov 14.

PMID:
29068471
9.

Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression.

Yang B, Zhang L, Cao Y, Chen S, Cao J, Wu D, Chen J, Xiong H, Pan Z, Qiu F, Chen J, Ling X, Yan M, Huang S, Zhou S, Li T, Yang L, Huang Y, Lu J.

Mol Cancer. 2017 Sep 25;16(1):154. doi: 10.1186/s12943-017-0722-8.

10.

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma.

Zhang Y, Xi S, Chen J, Zhou D, Gao H, Zhou Z, Xu L, Chen M.

J Cancer. 2017 Aug 25;8(15):2992-3000. doi: 10.7150/jca.21038. eCollection 2017.

11.

Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients.

Chen J, Huang J, Chen M, Yang K, Chen J, Wang J, Xu L, Zhou Z, Zhang Y.

J Cancer. 2017 Aug 25;8(15):2984-2991. doi: 10.7150/jca.20978. eCollection 2017.

12.

Expression of Pim-3 in colorectal cancer and its relationship with prognosis.

Zhou Z, Zhang R, Wang R, Zhang Y, Xu L, Chen J, Zhang J, Huang Z, Chen M, Pan Z.

Tumour Biol. 2016 Jul;37(7):9151-6. doi: 10.1007/s13277-016-4806-7. Epub 2016 Jan 14.

PMID:
26768612

Supplemental Content

Loading ...
Support Center